The CETSA screen also identified two other marketed drugs, triamterene, a sodium channel inhibitor used to treat hypertension, and pyrimethamine, an inhibitor of dihydrofolate reductase from Plasmodium falciparum that is used to treat malaria. The gene discussed is DHFR; the disease is malaria.